In lung cancer, this is accomplished through IQGAP3's regulation of EGFR-ERK signaling [34], whereas in hepatocellular carcinoma, this is accomplished by promoting TGF-β, which is a key EMT regulator [33]. This evidence concerns the gene EGFR and lung carcinoma.